Ming Yao

11.3k total citations · 1 hit paper
139 papers, 8.8k citations indexed

About

Ming Yao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ming Yao has authored 139 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 65 papers in Cancer Research and 39 papers in Oncology. Recurrent topics in Ming Yao's work include RNA modifications and cancer (39 papers), MicroRNA in disease regulation (24 papers) and Cancer-related molecular mechanisms research (24 papers). Ming Yao is often cited by papers focused on RNA modifications and cancer (39 papers), MicroRNA in disease regulation (24 papers) and Cancer-related molecular mechanisms research (24 papers). Ming Yao collaborates with scholars based in China, United States and Hong Kong. Ming Yao's co-authors include Jinjun Li, Jianren Gu, Chao Ge, Fangyu Zhao, Mingxia Yan, Xianghuo He, Taoyang Chen, Shenglin Huang, Wenxin Qin and Yingjun Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Yao

138 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

2017 436 citations Hui Wang, Xin‐Rong Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Yao China	52	6.3k	4.3k	1.9k	771	668	139	8.8k
Wenxin Qin China	44	5.3k 0.8×	3.3k 0.8×	1.4k 0.7×	853 1.1×	837 1.3×	137	7.7k
Jinjun Li China	45	4.8k 0.8×	3.1k 0.7×	1.7k 0.9×	553 0.7×	520 0.8×	137	7.0k
Alfred S.L. Cheng Hong Kong	51	5.4k 0.8×	2.5k 0.6×	1.4k 0.7×	747 1.0×	867 1.3×	146	8.2k
Fangyu Zhao China	42	3.7k 0.6×	2.8k 0.6×	1.3k 0.7×	633 0.8×	571 0.9×	124	5.5k
Giovanni Melillo United States	44	4.1k 0.7×	3.3k 0.8×	2.1k 1.1×	691 0.9×	1.5k 2.3×	102	7.9k
Wei‐Zhong Wu China	41	3.5k 0.5×	1.9k 0.4×	2.1k 1.1×	470 0.6×	1.0k 1.6×	107	5.7k
Yongquan Shi China	45	4.4k 0.7×	2.6k 0.6×	1.2k 0.6×	501 0.6×	438 0.7×	199	6.7k
Kalpana Ghoshal United States	42	6.4k 1.0×	4.9k 1.1×	1.1k 0.6×	260 0.3×	924 1.4×	88	9.1k
Wolfgang Mikulits Austria	44	4.1k 0.6×	1.6k 0.4×	2.4k 1.3×	646 0.8×	822 1.2×	116	6.9k
Peter E. Lobie China	58	5.2k 0.8×	2.8k 0.6×	2.4k 1.3×	621 0.8×	952 1.4×	233	9.4k

Countries citing papers authored by Ming Yao

Since Specialization

Citations

This map shows the geographic impact of Ming Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yao more than expected).

Fields of papers citing papers by Ming Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yao. The network helps show where Ming Yao may publish in the future.

Co-authorship network of co-authors of Ming Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Yao. A scholar is included among the top collaborators of Ming Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Yao. Ming Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Yiyi, Jian Gao, Peiying Li, et al.. (2023). Environmental eustress promotes liver regeneration through the sympathetic regulation of type 1 innate lymphoid cells to increase IL-22 in mice. Hepatology. 78(1). 136–149. 19 indexed citations

Zhang, Lili, Chao Ge, Fangyu Zhao, et al.. (2020). ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma. Cancer Research. 80(12). 2599–2611. 39 indexed citations

He, Jia, Qiaozhu Zuo, Bo Hu, et al.. (2019). A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. 450. 98–109. 98 indexed citations

Wu, Hai-Qiu, Cun Wang, Jiaxin Sun, et al.. (2019). Self-Assembled and Self-Monitored Sorafenib/Indocyanine Green Nanodrug with Synergistic Antitumor Activity Mediated by Hyperthermia and Reactive Oxygen Species-Induced Apoptosis. ACS Applied Materials & Interfaces. 11(47). 43996–44006. 39 indexed citations

Song, Zhen, Tengfei Liu, Jing Chen, et al.. (2019). HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib. Cancer Letters. 460. 96–107. 55 indexed citations

Li, Zhe, Jiwei Zhang, Xinyang Liu, et al.. (2018). The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nature Communications. 9(1). 1572–1572. 170 indexed citations

Song, Yanfang, Yu Gan, Qīng Wáng, et al.. (2017). Enriching the Housing Environment for Mice Enhances Their NK Cell Antitumor Immunity via Sympathetic Nerve–Dependent Regulation of NKG2D and CCR5. Cancer Research. 77(7). 1611–1622. 71 indexed citations

Yu, Tao, Yingjun Zhao, Zhixiang Hu, et al.. (2017). MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research. 77(21). 5782–5794. 142 indexed citations

Li, Shengli, Di Chen, Bing Chen, et al.. (2017). Transcriptomic analyses of RNA‐binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma. Cancer Science. 108(5). 877–885. 29 indexed citations

10.

Zhang, Jiwei, Zhe Li, Longzi Liu, et al.. (2017). Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway. Hepatology. 67(1). 171–187. 178 indexed citations

11.

Liu, Yiyao, Chao Ge, Hua Tian, et al.. (2017). The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.. PubMed Central. 7(6). 1285–1297. 19 indexed citations

12.

Zhang, Lixing, Chao Ge, Fangyu Zhao, et al.. (2016). NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling. Cancer Research. 76(23). 7059–7071. 36 indexed citations

13.

Yao, Ming, et al.. (2015). Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt. Clinical Cancer Research. 21(20). 4676–4685. 54 indexed citations

14.

Zhou, Yajie, Long Wang, Ming Yao, & Xia Zhou. (2015). Levels and values of serum uric acid in patients with multiple system atrophy. Chin J Neurol. 48(12). 1074–1078. 1 indexed citations

15.

Chen, Zhiao, Zhijun Wang, Weijie Guo, et al.. (2014). TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene. 34(30). 3946–3956. 73 indexed citations

16.

Li, Jie, Ying Xu, Xi‐Dai Long, et al.. (2014). Cbx4 Governs HIF-1α to Potentiate Angiogenesis of Hepatocellular Carcinoma by Its SUMO E3 Ligase Activity. Cancer Cell. 25(1). 118–131. 182 indexed citations

17.

Zhou, Min, Hai Wang, Keke Zhou, et al.. (2013). A Novel EGFR Isoform Confers Increased Invasiveness to Cancer Cells. Cancer Research. 73(23). 7056–7067. 20 indexed citations

18.

Jing, Ying, Deshui Jia, Chun‐Ming Wong, et al.. (2013). SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma. Molecular Oncology. 8(2). 366–377. 35 indexed citations

19.

Zhang, Lixing, Hefen Sun, Fangyu Zhao, et al.. (2012). BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma. Cancer Research. 72(16). 4276–4285. 82 indexed citations

20.

Shuin, Taro, Keiichi Kondo, Norio Sakai, et al.. (1995). [Results of mutation analyses of von Hippel-Lindau disease gene in Japanese patients: comparison with results in United States and United Kingdom].. PubMed. 41(9). 703–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact